JP2003522175A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003522175A5 JP2003522175A5 JP2001557867A JP2001557867A JP2003522175A5 JP 2003522175 A5 JP2003522175 A5 JP 2003522175A5 JP 2001557867 A JP2001557867 A JP 2001557867A JP 2001557867 A JP2001557867 A JP 2001557867A JP 2003522175 A5 JP2003522175 A5 JP 2003522175A5
- Authority
- JP
- Japan
- Prior art keywords
- oxazolidinyl
- morpholinyl
- acetamide
- oxo
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000002480 mineral oil Substances 0.000 claims 1
- 235000010446 mineral oil Nutrition 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17983700P | 2000-02-02 | 2000-02-02 | |
| US60/179,837 | 2000-02-02 | ||
| PCT/US2001/000657 WO2001057035A1 (en) | 2000-02-02 | 2001-01-29 | Linezolid-crystal form ii |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003522175A JP2003522175A (ja) | 2003-07-22 |
| JP2003522175A5 true JP2003522175A5 (enExample) | 2008-10-16 |
| JP5235256B2 JP5235256B2 (ja) | 2013-07-10 |
Family
ID=22658183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001557867A Expired - Lifetime JP5235256B2 (ja) | 2000-02-02 | 2001-01-29 | リネゾリド結晶形態ｉｉ |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1255754B1 (enExample) |
| JP (1) | JP5235256B2 (enExample) |
| KR (3) | KR100781815B1 (enExample) |
| CN (1) | CN1221547C (enExample) |
| AR (1) | AR027261A1 (enExample) |
| AT (1) | ATE297920T1 (enExample) |
| AU (1) | AU782138B2 (enExample) |
| BR (1) | BR0107667A (enExample) |
| CA (1) | CA2395603C (enExample) |
| CO (1) | CO5261555A1 (enExample) |
| CZ (1) | CZ302292B6 (enExample) |
| DE (1) | DE60111497T2 (enExample) |
| DK (1) | DK1255754T3 (enExample) |
| EA (1) | EA004434B1 (enExample) |
| EE (1) | EE05197B1 (enExample) |
| ES (1) | ES2242728T3 (enExample) |
| HU (1) | HUP0301076A3 (enExample) |
| IL (1) | IL151010A0 (enExample) |
| MX (1) | MXPA02007471A (enExample) |
| MY (1) | MY122829A (enExample) |
| NO (2) | NO323459B1 (enExample) |
| NZ (1) | NZ520541A (enExample) |
| PE (1) | PE20011086A1 (enExample) |
| PL (1) | PL356433A1 (enExample) |
| PT (1) | PT1255754E (enExample) |
| SI (1) | SI1255754T1 (enExample) |
| SK (1) | SK287025B6 (enExample) |
| TW (1) | TWI297687B (enExample) |
| WO (1) | WO2001057035A1 (enExample) |
| ZA (1) | ZA200205162B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100490643B1 (ko) * | 2002-10-29 | 2005-05-19 | 한국과학기술연구원 | 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법 |
| ES2803516T3 (es) | 2003-10-16 | 2021-01-27 | Symed Labs Ltd | Una forma cristalina de linezolid |
| ES2294494T3 (es) | 2004-04-19 | 2008-04-01 | Symed Labs Limited | Un nuevo procedimiento para la preparacion de linezolid y compuestos relacionados. |
| EP1658275A1 (en) * | 2004-06-29 | 2006-05-24 | Teva Pharmaceutical Industries Ltd | Crystalline form iv of linezolid |
| EP1745028A2 (en) * | 2004-06-29 | 2007-01-24 | Teva Pharmaceutical Industries Ltd | Solid forms of linezolid and processes for preparation thereof |
| WO2006091731A2 (en) * | 2005-02-24 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of linezolid intermediate |
| KR20070062504A (ko) * | 2005-06-22 | 2007-06-15 | 테바 파마슈티컬 인더스트리즈 리미티드 | 테가세로드 말레이트의 다형태 |
| DK1749517T3 (da) * | 2005-07-20 | 2008-11-03 | Teva Pharma | Stabil farmaceutiske sammensætning af linezolid form IV |
| WO2007102082A1 (en) * | 2006-03-09 | 2007-09-13 | Glenmark Pharmaceuticals Limited | High oxazolidinone content solid dosage forms |
| WO2008127300A2 (en) * | 2006-10-23 | 2008-10-23 | Concert Pharmaceuticals Inc. | Oxazolidinone derivatives and methods of use |
| WO2011050826A1 (en) | 2009-10-28 | 2011-05-05 | Synthon B.V. | Process for making crystalline form a of linezolid |
| CN103025730A (zh) | 2010-04-30 | 2013-04-03 | 印第安纳大学研究及科技有限公司 | 制备利奈唑胺的方法 |
| EP2690100A1 (en) | 2010-08-11 | 2014-01-29 | Synhton B.V. | Process for making linezolid |
| WO2012019632A1 (en) | 2010-08-11 | 2012-02-16 | Synthon B.V. | Process for making linezolid |
| EP2593440A1 (en) * | 2011-02-24 | 2013-05-22 | Lee Pharma Limited | Anhydrous linezolid crystalline form-ii |
| WO2012119653A1 (en) | 2011-03-09 | 2012-09-13 | Synthon Bv | Process for making crystalline form a of linezolid |
| CN102731341A (zh) * | 2011-04-13 | 2012-10-17 | 上海医药工业研究院 | 用于制备利奈唑胺的中间体及其制备方法 |
| CN105461648B (zh) * | 2011-05-03 | 2018-01-12 | 江苏豪森药业集团有限公司 | 利奈唑胺的晶型及其制备方法 |
| CN102399200B (zh) * | 2011-12-14 | 2013-12-04 | 浙江新东港药业股份有限公司 | 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法 |
| WO2013111048A1 (en) | 2012-01-24 | 2013-08-01 | Jubilant Life Sciences Limited | Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent |
| WO2013120496A1 (en) | 2012-02-14 | 2013-08-22 | Pharmathen S.A. | Process for the preparation of linezolid in crystalline form and salts thereof |
| CN102643245A (zh) * | 2012-04-10 | 2012-08-22 | 杭州华东医药集团生物工程研究所有限公司 | 一种利奈唑胺晶型及其制备方法 |
| ES2603252T3 (es) | 2012-11-09 | 2017-02-24 | Synthon Bv | Proceso para preparar linezolid |
| US20190343761A1 (en) | 2016-11-16 | 2019-11-14 | Persica Pharmaceuticals Ltd. | Antibiotic formulations for lower back pain |
| EP3709970B1 (en) * | 2017-11-16 | 2025-05-14 | Persica Pharmaceuticals Ltd. | Linezolid formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| MY115155A (en) * | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| SG85683A1 (en) * | 1996-04-11 | 2002-01-15 | Upjohn Co | Process to prepare oxazolidinones |
| NZ504372A (en) * | 1997-11-07 | 2002-12-20 | Upjohn Co | Process to produce N-[3-fluoro-4(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinones |
-
2001
- 2001-01-22 AR ARP010100269A patent/AR027261A1/es not_active Application Discontinuation
- 2001-01-25 PE PE2001000080A patent/PE20011086A1/es not_active Application Discontinuation
- 2001-01-26 CO CO01005901A patent/CO5261555A1/es not_active Application Discontinuation
- 2001-01-29 JP JP2001557867A patent/JP5235256B2/ja not_active Expired - Lifetime
- 2001-01-29 AT AT01904805T patent/ATE297920T1/de active
- 2001-01-29 BR BR0107667-1A patent/BR0107667A/pt not_active Application Discontinuation
- 2001-01-29 NZ NZ520541A patent/NZ520541A/en not_active IP Right Cessation
- 2001-01-29 MX MXPA02007471A patent/MXPA02007471A/es active IP Right Grant
- 2001-01-29 WO PCT/US2001/000657 patent/WO2001057035A1/en not_active Ceased
- 2001-01-29 ES ES01904805T patent/ES2242728T3/es not_active Expired - Lifetime
- 2001-01-29 EA EA200200819A patent/EA004434B1/ru not_active IP Right Cessation
- 2001-01-29 DE DE60111497T patent/DE60111497T2/de not_active Expired - Lifetime
- 2001-01-29 HU HU0301076A patent/HUP0301076A3/hu unknown
- 2001-01-29 AU AU32755/01A patent/AU782138B2/en not_active Ceased
- 2001-01-29 PT PT01904805T patent/PT1255754E/pt unknown
- 2001-01-29 EP EP01904805A patent/EP1255754B1/en not_active Expired - Lifetime
- 2001-01-29 CA CA2395603A patent/CA2395603C/en not_active Expired - Lifetime
- 2001-01-29 KR KR1020027009923A patent/KR100781815B1/ko not_active Expired - Fee Related
- 2001-01-29 DK DK01904805T patent/DK1255754T3/da active
- 2001-01-29 KR KR1020087010742A patent/KR20080044358A/ko not_active Ceased
- 2001-01-29 EE EEP200200420A patent/EE05197B1/xx not_active IP Right Cessation
- 2001-01-29 IL IL15101001A patent/IL151010A0/xx active IP Right Grant
- 2001-01-29 CZ CZ20022635A patent/CZ302292B6/cs not_active IP Right Cessation
- 2001-01-29 CN CNB018034489A patent/CN1221547C/zh not_active Expired - Fee Related
- 2001-01-29 MY MYPI20010371A patent/MY122829A/en unknown
- 2001-01-29 SK SK994-2002A patent/SK287025B6/sk not_active IP Right Cessation
- 2001-01-29 PL PL01356433A patent/PL356433A1/xx unknown
- 2001-01-29 KR KR1020077016678A patent/KR100864745B1/ko not_active Expired - Fee Related
- 2001-01-29 SI SI200130405T patent/SI1255754T1/sl unknown
- 2001-02-02 TW TW090102231A patent/TWI297687B/zh not_active IP Right Cessation
-
2002
- 2002-06-27 ZA ZA200205162A patent/ZA200205162B/en unknown
- 2002-08-01 NO NO20023654A patent/NO323459B1/no not_active IP Right Cessation
-
2006
- 2006-12-15 NO NO20065836A patent/NO20065836L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2013018I1 (lt) | 4-oksochinolino junginiai ir jų, kaip živ inregrazės inhibitorių, panaudojimas | |
| JP2005526058A5 (enExample) | ||
| AU2003264204A1 (en) | Portable high speed internet access device priority protocol | |
| IL176283A0 (en) | Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof | |
| NO20031923D0 (no) | Ny behandling av "restless legs" syndrom | |
| JP2002519422A5 (enExample) | ||
| NO20034127D0 (no) | Forbedring av aromainneholdende bestanddeler | |
| ATE296302T1 (de) | 4-(1,3,4-thiadiazolyl-2-yl)-1,4-diazabizyklo- 3.2.2 nonanderivate, ihre herstellung und ihre therapeutische verwendung | |
| JP2005510235A5 (enExample) | ||
| DE60100927D1 (de) | Verbesserter Internet Protocolpaketrouter | |
| DE60200427D1 (de) | Vernetzbare Fluorelastomerzusammensetzungen, ihre Herstellung und Verwendung | |
| ATE290534T1 (de) | 4-(oxadiazol-3-yl)-1,4-diazabizyklo(3.2.2)- nonanderivate, ihre herstellung und therapeutische verwendung | |
| JP2000028062A5 (enExample) | ||
| CO5261555A1 (es) | Linezolid-forma cristalina ii | |
| JP2005536339A5 (enExample) | ||
| IS2473B (is) | Samsetning sem inniheldur N-(3-metoxý-5-metýlpýrasín-2-ýl)-2-(4-(1,3,4-oxadíasól-2-ýl)fenýl)pýridín-3-súlfónamíð (ZD4054), eða lyfjafræðilega viðurkennt salt þess, og EGFR TKI, eða lyfjafræðilega viðurkennt salt þess | |
| DE60307918D1 (de) | Rotationsdämpfer | |
| AU2001291714A1 (en) | Flywheel comprising an oscillation damper that adapts to the rotational speed | |
| JP2004517961A5 (enExample) | ||
| JP2005536763A5 (enExample) | ||
| JP2005005118A5 (enExample) | ||
| JP2003504349A5 (enExample) | ||
| DK1240163T3 (da) | 3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler | |
| NO20052803D0 (no) | Komplekser av e-2-metoksy-n-(3-{4-(3-metyl-pyridin-3-yloksy)-fenylam ino)-kinazolin-6-yl}-allyl)acetamid, deres fremstillingsmate og bruk | |
| JP2002277470A5 (enExample) |